DCF — TEXAS HEALTH HARRIS METHODIST STEPHE
Enterprise Value: $71.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$71.6M
Enterprise Value
$19.4M
PV of Cash Flows
$52.2M
PV of Terminal Value
$84.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $68.2M | $8.7M | 13.0% | $4.1M | $3.7M |
| Year 2 | $70.2M | $9.6M | 14.0% | $4.7M | $3.9M |
| Year 3 | $72.3M | $10.7M | 15.0% | $5.4M | $4.0M |
| Year 4 | $74.5M | $11.4M | 15.0% | $5.8M | $4.0M |
| Year 5 | $76.7M | $11.9M | 15.0% | $6.1M | $3.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $71.6M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$66.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1224178202204188
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5